WallStSmart

Lineage, Inc. Common Stock (LINE)vsPower REIT (PW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 266080% more annual revenue ($5.36B vs $2.01M). LINE leads profitability with a -1.9% profit margin vs -109.1%. LINE earns a higher WallStSmart Score of 36/100 (F).

LINE

Hold

36

out of 100

Grade: F

Growth: 3.3Profit: 3.5Value: 6.7Quality: 3.8
Piotroski: 5/9Altman Z: 0.81

PW

Avoid

20

out of 100

Grade: F

Growth: 2.0Profit: 3.0Value: 4.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LINEUndervalued (+75.9%)

Margin of Safety

+75.9%

Fair Value

$161.49

Current Price

$35.99

$125.50 discount

UndervaluedFair: $161.49Overvalued

Intrinsic value data unavailable for PW.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PW0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

LINE4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-1.2%2/10

ROE of -1.2% — below average capital efficiency

Revenue GrowthGrowth
-0.2%2/10

Revenue declined 0.2%

Altman Z-ScoreHealth
0.812/10

Distress zone — elevated risk

PW4 concerns · Avg: 2.3/10
Market CapQuality
$2.82M3/10

Smaller company, higher risk/reward

PEG RatioValuation
3.982/10

Expensive relative to growth rate

Return on EquityProfitability
-36.9%2/10

ROE of -36.9% — below average capital efficiency

Revenue GrowthGrowth
-11.2%2/10

Revenue declined 11.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : PW

PW has a balanced fundamental profile.

Bear Case : LINE

The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.

Bear Case : PW

The primary concerns for PW are Market Cap, PEG Ratio, Return on Equity.

Key Dynamics to Monitor

LINE is growing revenue faster at -0.2% — sustainability is the question.

LINE generates stronger free cash flow (78M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

LINE scores higher overall (36/100 vs 20/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.

Visit Website →

Power REIT

REAL ESTATE · REIT - SPECIALTY · USA

Power REIT is a real estate investment trust (REIT) that owns real estate related to infrastructure assets, including properties for controlled environment agriculture, renewable energy, and transportation.

Want to dig deeper into these stocks?